Tag: Parkinson’s Research

A new drug target for chemically induced Parkinson’s disease

More than three decades ago, scientists discovered that a chemical found in a synthetic opioid, MPTP, induced the onset of a form of Parkinson’s disease. In a new study led by scientists from the School of Veterinary Medicine, researchers found that an enzyme in the body can metabolize compounds formed in the brain from alkaloids

Massive sequencing study links rare DNA alterations to type 2 diabetes: Scientists identify new genetic targets for disease research and potentially drug development

An international consortium of scientists has analyzed protein-coding genes from nearly 46,000 people, linking rare DNA alterations to type 2 diabetes. The study, one of the largest known of its type, includes data from people of European, African American, Hispanic/Latino, East Asian, and South Asian ancestries. From this large cohort — roughly 21,000 individuals with

Appendix removal associated with development of Parkinson’s disease: Data from 62 million records explores relationship between the gut and the nervous system disorder

Patients who had their appendix removed were more likely to develop Parkinson’s disease than those whose appendix remained in place, according to the largest study to address the relationship between the two conditions. The retrospective study involving more than 62 million patient records from 26 health systems will be presented at Digestive Disease Week® (DDW)

Sensory neurons can be used to discover therapies for ALS: New approach for testing for ALS may be useful to reverse debilitating disease

Virginia Tech Carilion Research Institute scientists have shown that mutations in specific genes that destroy motor neurons and thereby cause the devastating effects of amyotrophic lateral sclerosis — also known as ALS or Lou Gehrig’s disease — also attack sensory neurons. The discovery in today’s (Thursday, Nov. 8) Scientific Reports indicates that studying sensory neurons

Electricity sparks neuronal diversity during brain development: Bioelectrical potential is driving force for stem cells to generate different types of neurons during embryogenesis

The cerebral cortex is a highly developed brain region, which allows intellectual functions such as conscious perception, anticipation of events and language. These functions are mediated by specific sets of neuronal circuits. To understand how these circuits emerge during development, researchers from the University of Geneva (UNIGE), Switzerland, in collaboration with an American team, investigated

Sleep problems in Parkinson’s disease: Can we fix them?

A team of researchers at VIB and KU Leuven has uncovered why people with a hereditary form of Parkinson’s disease suffer from sleep disturbances. The molecular mechanisms uncovered in fruit flies and human stem cells also point to candidate targets for the development of new treatments. Sleep and Parkinson’s Parkinson’s disease affects 5 million people

Scientists show how brain circuit generates anxiety: Research suggests a possible target for future anti-anxiety drugs

Neuroscientists at Cold Spring Harbor Laboratory (CSHL) have identified a neural circuit in the amygdala, the brain’s seat of emotion processing, that gives rise to anxiety. Their insight has revealed the critical role of a molecule called dynorphin, which could serve as a target for treatment of anxiety-related disorders including post-traumatic stress disorder (PTSD). Though

Link between tuberculosis and Parkinson’s disease discovered: The mechanism our immune cells use to clear bacterial infections like tuberculosis (TB) might also be implicated in Parkinson’s disease

The mechanism our immune cells use to clear bacterial infections like tuberculosis (TB) might also be implicated in Parkinson’s disease, according to a new collaborative study led by the Francis Crick Institute, Newcastle University and GSK. The findings, which will be published in The EMBO Journal, provide a possible explanation of the cause of Parkinson’s

EPO protects preemies’ brains by modifying genes essential for generating new brain cells: Modified genes are essential for neurogenesis and responding to environmental stressors

Erythropoietin (EPO) helps to protect and repair vulnerable brains though it remains a mystery how the anemia drug does so. Genetic analyses conducted by a multi-institutional research team finds that EPO may work its neuroprotective magic by modifying genes essential for regulating growth and development of nervous tissue as well as genes that respond to

Gene variant increases empathy-driven fear in mice

Researchers at the Center for Cognition and Sociality, within the Institute for Basic Science (IBS), have just published in Neuron about a genetic variant that controls and increases empathy-driven fear in mice. As empathy is evolutionarily conserved from rodents to humans, this finding might contribute to clarify individual variability in neuropsychiatric conditions characterized by empathic

Dementia: How circadian clock controls daily rhythms of aggression: New findings shed light on the early-evening agitation known as ‘sundowning,’ common in patients with dementia and Alzheimer’s disease

Patients with Alzheimer’s disease and other forms of dementia commonly experience the sundown syndrome — a sudden worsening of confusion, agitation and aggression at the end of the day. Its daily pattern suggested that “sundowning,” as the phenomenon is also known, may be governed by the body’s internal biological clock. Synchronized by light and darkness,